A5015534010- SARS-CoV-2 and COVID-19 Research
- Mosquito-borne diseases and control
- Viral Infections and Vectors
- Hepatitis Viruses Studies and Epidemiology
- COVID-19 Clinical Research Studies
- Malaria Research and Control
- Hepatitis B Virus Studies
- Hepatitis C virus research
- Immune responses and vaccinations
- Heparin-Induced Thrombocytopenia and Thrombosis
- Viral Infections and Outbreaks Research
- Liver Diseases and Immunity
- Long-Term Effects of COVID-19
- interferon and immune responses
- Travel-related health issues
- Vector-borne infectious diseases
- Viral gastroenteritis research and epidemiology
Örebro University
2017-2024
Örebro University Hospital
2017-2024
Qdenga® has been approved by the European Medicines Agency (EMA) for individuals > 4 years of age and use according to national recommendations. The vaccine shows high efficacy against virologically confirmed dengue severe in clinical studies on 4-16-year old's living endemic areas. For 16-60 old only serological data exists there is no 60 years. Its as a travel still unclear. We present behind approval recommendations travelers issued Swedish Society Infectious Diseases Physicians.
Southern Sweden is endemic for tick-borne encephalitis (TBE), with Stockholm County as one of the high-risk areas. Our aim in this study was to describe cases vaccine failures and optimize future vaccination recommendations.Patients TBE were identified notification database at Department Communicable Disease Control Prevention during 2006-2015. Vaccine failure defined despite adherence recommended schedule least 2 doses. Clinical data extracted from medical records.A total 1004 identified,...
mRNA vaccines are likely to become widely used for the prevention of infectious diseases in future.Nevertheless, a notable gap exists mechanistic data, particularly concerning potential effects sequential immunization or preexisting immunity on early innate immune response triggered by vaccination.In this study, healthy adults, with without documented prior SARS-CoV-2 infection, were vaccinated BNT162b2/Comirnaty vaccine.Prior infection conferred significantly stronger induction...
This paper discusses challenges in formulating and harmonizing malaria prevention recommendations for travellers. It explores diverse approaches used by advisory groups to assess risk shares insights from the 2023 International Expert Committee Travel Medicine meeting. also future prospects enhancing
The mRNA vaccines have proven to be very effective in preventing severe disease and death from SARS-CoV-2 the general population. However, patients with chronic kidney (CKD) dialysis or transplants (KT) vaccine responses vary, breakthrough infections as a consequence. In this intervention study we investigated magnitude quality of vaccination administered prior replacement therapy (KRT). Twenty CKD G4/5 nine healthy controls were followed for 12 months after receiving two doses BNT162b2 four...
The mRNA vaccines have proven to be very effective in preventing severe disease and death from SARS-CoV-2 the general population. However, patients with chronic kidney (CKD) dialysis or transplants (KT) vaccine responses vary, breakthrough infections as a consequence. In this intervention study we investigated magnitude quality of vaccination administered prior renal replacement therapy (RRT). Twenty CKD stage 4/5 nine healthy controls were followed for 12 months after receiving two doses...